Delivery Order SPE2DB24D2106-SPE2DB25FAVAT

Award Date 4/16/25
Potential Completion Date 4/17/25
Potential Value $24K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $7,579.97, is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml to support the medical supply needs of military healthcare facilities. The contract has an ultimate completion date of January 10, 2025 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a...
The Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract worth $1,935.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Ozempic 0.25-0.5 mg/dose pens. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC allows the DLA to issue...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,374.60, is for the supply of Ozempic 0.25-0.5 mg/dose pen in 1.5 mL for the DLA. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which allows the agency to...
This is a $18,614.39 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a completion date of January 16, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a wide range of pharmaceutical...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The $4,838.10 order is for the pharmaceutical product Ozempic 0.25-0.5 mg/dose pen 1.5mL, with a completion date of January 6, 2023. DMS Pharmaceutical Group holds a single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999 through December...
This federal contract award, identified as SPE2DB24D2106|SPE2DB25FATXY, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. The contract has a fixed-price structure and a ceiling value of $16,180.32, with an ultimate...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $19,352.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract covers the supply of Ozempic 0.25-0.5 mg/dose pens to support the recurring medical needs of military healthcare facilities. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $2,019.24, is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The contract has an ultimate completion date of March 25, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML pharmaceutical products to the Defense Logistics Agency Troop Support Medical in Park Ridge, Illinois. The contract has a firm fixed price of $2,580.32 and a completion date of February 1, 2024. DMS Pharmaceutical Group Inc. holds a broader indefinite delivery contract with the Defense Logistics Agency, contract 4600082013 under the SPE2DB...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,870.48 firm fixed-price contract is for the delivery of Ozempic 0.25-0.5 mg/dose pens. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a wide range of pharmaceutical...
  • SPE2DB24D2106
    Indefinite Delivery Contract
  • SPE2DB24D2106-SPE2DB25FAVAT
    Delivery Order

This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA). The contract is a Delivery Order under the SPE2DB program, with a ceiling value of $24,438.32 and an ultimate completion date of April 17, 2025. The contract is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to the DLA. This contract is not set aside and is a firm fixed-price contract. DMS Pharmaceutical Group Inc. is a crucial supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites under a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which is valid through November 2026.

Generated 7/16/25, 12:24 PM